What is CareDx's impairment of assets and other charges?

CareDx (CDNA) reported impairment of assets and other charges of $0 in Q4 2025.

What is the long-term trend for CareDx's impairment of assets and other charges?

Over 2 years (2023 to 2025), CareDx's impairment of assets and other charges has grown at a -100.0% compound annual growth rate (CAGR), from $1M to $0.

CareDx CDNA Impairment of assets and other charges

Impairment of assets and other charges at other companies

Guardant HealthGH

——

Other financials

Income statement

See full

Revenue$117.7M+39.0%

Operating income$1.2M+109%

Net income$2.8M+127%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$78.5M-12.1%

Total debt$24.5M-19.1%

Total equity$313.5M-17.3%

Total assets$411.1M-16.0%

Cash flow

See full

Operating cash flow$4.3M+116%

CapEx$3.8M+134%

Free cash flow$514.0K+102%

Valuation

See full

Market cap$1.4B+32.2%

Enterprise value$1.35B+34.6%

P/S3.4×+0.3×

Profitability

See full

Gross margin65.5%—

Operating margin-3.9%-18.3pp

Net margin-2%-19.9pp

FCF margin-0%0.0pp

Returns & leverage

See full

Return on equity-2.4%-21.9pp

Debt / equity0.1×0.0×

Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetImpairmentCharges.

The official record: CareDx’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's impairment of assets and other charges.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CareDx's impairment of assets and other charges?: CareDx (CDNA) reported impairment of assets and other charges of $0 in Q4 2025.
What is the long-term trend for CareDx's impairment of assets and other charges?: Over 2 years (2023 to 2025), CareDx's impairment of assets and other charges has grown at a -100.0% compound annual growth rate (CAGR), from $1M to $0.